Apollo Hospitals will leverage AI for Heart

New Delhi: Apollo Hospitals’ avowed aim of fighting against tsunami of Non Communicable Diseases (NCD) including cardiovascular disease has got a force multiplier in Microsoft. This partnership will lead to the prediction of the risk of cardiovascular disease in the Indian population.

As part of Microsoft’s AI Network for Healthcare initiative, Microsoft India and Apollo Hospitals Group have joined hands to set up a National Clinical Coordination Committee (NCCC) for AI-powered Cardiovascular Disease Risk Score API.

According to a press release NCCC will assist the core team at Apollo Hospitals and Microsoft by providing guidance on all cardiology and cardiovascular-related artificial intelligence projects; insights on developing clinical algorithm and treatment guidelines based on the inferences of national, multi-centre prospective study, a release said here.

‘The NCCC is a great step forward as part of our partnership with Apollo. We are also engaging global consortium partners to scale the AI-powered API (application programme interface),’ Microsoft, Cloud & Enterprise, Corporate Vice President, Anil Bhansali said,

‘We have already received approval for a pilot study and we hope that the findings will enable physicians to better understand the causes of CVDs in Indian population,’ he further said.

Speaking about the National Clinical Coordination Committee, Apollo Hospitals Group, Joint Managing Director, Sangita Reddy, said, ‘The NCCC will help us immensely in our fight against the rising tsunami of Non-Communicable Diseases (NCDs).’

According to the release, cardiovascular diseases (CVDs) are the biggest cause of mortality in India with nearly 25 percent mortalities in the age group of 25 to 69 years. The condition also seems to affect Indians at least a decade earlier as compared to the Europeans.

Given the high prevalence of CVDs among Indians, Apollo Hospitals and Microsoft India, in 2018, launched the first ever AI-powered CVD Risk Score API, designed specifically to predict the risk of cardiovascular disease in the Indian population, it said.

Built on Microsoft Azure, the API aims to determine a more accurate CVD risk score for the Indian population taking into consideration risk factors including lifestyle attribute like diet, tobacco and smoking preferences, physical activity and psychological stress and anxiety.

Related Posts

SSI Mantra, Made in India Robot, bats a Thousand by completing 100 Telesurgeries

Robotic Surgery Champs of India congregated @SS Innovations Headquarters in Gurgaon to script World Record Gurugram/ New Delhi: SSI Mantra, the ‘Only Made in India’ surgical robot is now like…

Swell of Footfalls for Respiratory & Cardiac Emergencies in Aakash Healthcare due to Pollution

Experts of the Multispecialty Hospital warn of the Consequences for Children and Elderly New Delhi: Pollution woes in Delhi are piling up and showing in hospitals. Swell of footfalls in…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

National Pharmaceutical Pricing Authority fixes retail price of 37 new drugs

National Pharmaceutical Pricing Authority fixes retail price of 37 new drugs

Massive Drug Bust in Bijnor: CBN Seizes Over 6.5 Lakh Tablets

Massive Drug Bust in Bijnor: CBN Seizes Over 6.5 Lakh Tablets

Sun Pharma unit recalls 17,000-plus bottles of antifungal shampoo in US

Sun Pharma unit recalls 17,000-plus bottles of antifungal shampoo in US

Strides Pharma Science arm New York facility gets 4 USFDA observations

Strides Pharma Science arm New York facility gets 4 USFDA observations

SSI Mantra, Made in India Robot, bats a Thousand by completing 100 Telesurgeries

SSI Mantra, Made in India Robot, bats a Thousand by completing 100 Telesurgeries

Bihar drug bust: Rs15 million narcotics seized in major trafficking crackdown

Bihar drug bust: Rs15 million narcotics seized in major trafficking crackdown